369
Views
2
CrossRef citations to date
0
Altmetric
Articles

“Quite a Profoundly Strange Experience”: An Analysis of the Experiences of Salvia divinorum Users

, Ph.D., , Ph.D. & , B.A.
Pages 206-213 | Received 27 Jul 2015, Accepted 29 Mar 2016, Published online: 13 May 2016

References

  • Al-Hasani, R., J. G. McCall, G. Shin, A. M. Gomez, G. P. Schmitz, J. M. Bernardi, C. O. Pyo, S. I. Park, C. M. Marcinkiewcz, N. A. Crowley, M. J. Krashes, B. B. Lowell, T. L. Kash, J. A. Rogers, and M. R. Bruchas. 2015. Distinct subpopulations of nucleus accumbens dynorphin neurons drive aversion and reward. Neuron 87 (5):1063–77. doi:10.1016/j.neuron.2015.08.019.
  • Becker, H. 1953. Becoming a marihuana user. American Journal of Sociology 59 (3):235–42. doi:10.1086/221326.
  • Buchanan, J. 2008. Understanding and engaging with problematic substance use. In Addressing offending behaviour: Context, practice, values, ed. S. Green, E. Lancaster, and S. Feasey, 246–264. Devon: Willan Publishing.
  • Bucheler, R., C. H. Gleiter, P. Schwoerer, and I. Gaertner. 2005. Use of nonprohibited hallucinogenic plants: Increasing relevance for public health? A case report and literature review on the consumption of Salvia divinorum (Diviner’s Sage). Pharmacopsychiatry 38:1–5. doi:10.1055/s-2005-837763.
  • Coomber, R., K. McElrath, F. Measham, and K. Moore. 2013. Key concepts in drugs and society. London: Sage.
  • Dalgarno, P. D., and D. Shewan. 2005. Reducing the risks of drug use: The case for set and setting. Addiction Research & Theory 13 (3):259–65. doi:10.1080/16066350500053562.
  • DeLanda, M. 2005. Space: Extensive and intensive, actual and virtual. In Deleuze and space, ed. I. Buchanan and G. Lambert. Edinburgh: Edinburgh University Press.
  • Duff, C. 2008. The pleasure in context. International Journal of Drug Policy 19:384–92. doi:10.1016/j.drugpo.2007.07.003.
  • Fitzgerald, J. 2002. A political economy of “Doves.” Contemporary Drug Problems 29 (1):201–39.
  • Gonzalez, D., J. Riba, J. C. Bouso, G. Gomez-Jarabo, and M. J. Barbanoj. 2006. Pattern of use and subjective effects of Salvia divinorum among recreational users. Drug and Alcohol Dependence 85:157–62. doi:10.1016/j.drugalcdep.2006.04.001.
  • Kelly, B. C. 2011. Legally tripping: A qualitative profile of salvia divinorum use among young adults. Journal of Psychoactive Drugs 43 (1):46–54. doi:10.1080/02791072.2011.566500.
  • Khey, D., J. M. Stogner, and B. C. Miller. 2014. Emerging trends in drug use and distribution. Cham, Switzerland: Springer International.
  • Khey, D. N., B. L. Miller, and O. H. Griffin. 2008. Salvia divinorum use among a college student sample. Journal of Drug Education 38 (3):297–306. doi:10.2190/DE.38.3.g.
  • Lange, J. E., M. B. Reed, J. M. Ketchie Croff, and J. D. Clapp. 2008. College student use of Salvia divinorum. Journal of Drug and Alcohol Dependence 94:263–66. doi:10.1016/j.drugalcdep.2007.10.018.
  • Levy, K., K. O’Grady, E. Wish, and A. Arria. 2005. An in-depth qualitative examination of the ecstasy experience: Results of a focus group with ecstasy using college students. Substance Use and Misuse 40 (12):1427–41. doi:10.1081/JA-200066810.
  • Lovheim, H. 2012. A new three-dimensional model for emotions and monoamine neurotransmitters. Medical Hypotheses 78 (2):341–48. doi:10.1016/j.mehy.2011.11.016.
  • Maclean, K., M. Johnson, C. Reissig, T. Prisinzano, and R. Griffiths. 2013. Dose-related effects of salvinorin A in humans: Dissociative, hallucinogenic and memory effects. Psychopharmacology 26:381–92. doi:10.1007/s00213-012-2912-9.
  • Maclean, S. 2005. “It might be a scummy-arsed drug but it’s a sick buzz”: Chroming and pleasure. Contemporary Drug Problems 32 (2):295–318.
  • Malins, P. 2004. Body-space assemblages and folds theorizing the relationship between injecting drug user bodies and urban space. Continuum 18:483–95. doi:10.1080/1030431042000297617.
  • Measham, F., J. Aldridge, and H. Parker. 2001. Dancing on drugs: Risk, health and hedonism in the British club scene. London: Free Association Books.
  • Miller, B. L., J. M. Stogner, D. N. Khey, R. L. Akers, J. Boman, and O. H. Griffin. 2011. Magic Mint, the Internet, and peer associations: A test of Social Learning Theory using patterns of salvia divinorum use. Journal of Drug Issues 41 (3):305–25. doi:10.1177/002204261104100301.
  • Ministry of Health. 2010. Drug use in New Zealand: Key results of the 2007/08 New Zealand alcohol and drug use survey. Wellington, New Zealand: Ministry of Health.
  • Moore, K., F. Measham, C. Griffin, Y. Morey, and S. Riley. 2008. The social and cultural uses of ketamine. Addiction Research and Theory 16 (3):205–07. doi:10.1080/16066350801983731.
  • New Zealand Drug Foundation. 2012. Salvia. Retrieved from http://www.drugfoundation.org.nz/salvia
  • Psychoactive Substances Act. 2013. Psychoactive Substances Act 2013. http://www.legislation.govt.nz/act/public/2013/0053/latest/DLM5042921.html?src=qs ( accessed August 5, 2014).
  • Psychoactive Substances Amendment Act. 2014. Psychoactive Substances Amendment Act 2014 http://www.legislation.govt.nz/act/public/2014/0024/latest/whole.html ( accessed August 5, 2014).
  • Rhodes, T. 2009. Risk environments and drug harms: A social science for harm reduction approach. Journal of Drug Policy 20 (3):193–201. doi:10.1016/j.drugpo.2008.10.003.
  • Rosenbaum, C., S. Carreiro, and K. Babu. 2012. Here today, gone tomorrow… and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, salvia divinorum, methoxetamine, and piperazines. Journal of Medical Toxicology 8 (1):15–32. doi:10.1007/s13181-011-0202-2.
  • Roth, B. L., K. Baner, R. Westkaemper, D. Siebert, K. C. Rice, S. Steinberg, and R. B. Rothman. 2002. Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist. Proceedings of the National Academy of Sciences of the United States of America 99 (18):11934–39. doi:10.1073/pnas.182234399.
  • Siebert, D. J. 1994. Salvia divinorum and salvinorin A: New pharmacologic findings. Journal of Ethnopharmacology 43:53–56. doi:10.1016/0378-8741(94)90116-3.
  • Stogner, J., D. N. Khey, H. Griffin III, B. L. Miller, and J. H. Boman IV. 2012. Regulating a novel drug: An evaluation of changes in use of Salvia divinorum in the first year of Florida’s ban. International Journal of Drug Policy 23:512–21. doi:10.1016/j.drugpo.2012.03.001.
  • Stogner, J. M., and B. L. Miller. 2013. Perception vs. reality: An investigation of the misperceptions concerning the extent of peer novel drug use. Journal of Drug Education 43 (2):97–120. doi:10.2190/DE.43.2.a.
  • The Dominion Post. 2008. Hallucinogenic herb legal to use in NZ. http://www.stuff.co.nz/dominion-post/archive/national-news/558614/Hallucinogenic.
  • Weitlaner, R. J. 1952. Curaciones mazatecas. Analysis Institute Nac Antropol Historical México 4:279–285.
  • Wilkins, C. 2014. A critical first assessment of the new pre-market approval regime for new psychoactive substances (NPS) in New Zealand. Addiction 109 (10):1580–86. doi:10.1111/add.2014.109.issue-10.
  • Wilkins, C., J. Prasad, K. Wong, and M. Rychert. 2014. Recent trends in illegal drug use in New Zealand 2006–2013: Findings from the 2006, 2007, 2008, 2009, 2010, 2011, 2012 and 2013 illicit drug monitoring system (IDMS). Auckland, New Zealand: SHORE and Whariki Research Centre, Massey University.
  • Zinberg, N. 1984. Drug set and setting: The basis for controlled intoxicant use. New Haven, CT: Yale University Press.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.